awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34429203-12016676-B345-4B7B-9494-524D57E28D8D
Q34429203-12016676-B345-4B7B-9494-524D57E28D8D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34429203-12016676-B345-4B7B-9494-524D57E28D8D
Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.
P2860
Q34429203-12016676-B345-4B7B-9494-524D57E28D8D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34429203-12016676-B345-4B7B-9494-524D57E28D8D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9f4121b51ee078109d058ffe26de833812b345b0
P2860
IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis